GlassScriptPhysician profile
Craig A Block
NPI 1154530137
$3,428.58
in general payments reported to CMS, 2019-2025
34 companies · $460 in 2025
The $460 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $177 · 2021: $303 · 2022: $1,347 · 2023: $441 · 2024: $290 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $1,052.62 | 2022 | |
| Edap Technomed INC | $318.37 | 2023-2024 | |
| Astellas Pharma US INC | $239.84 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Boston Scientific Corporation | $205.82 | 2020-2025 | Spaceoar Vue System - 10ml |
| Urogen Pharma, INC. | $199.82 | 2021-2025 | Jelmyto |
| Histosonics, INC. | $170.63 | 2025 | |
| Procept Biorobotics Corporation | $143.88 | 2020-2025 | |
| Pfizer INC. | $136.98 | 2021-2025 | |
| Abbvie INC. | $136.41 | 2022-2025 | |
| Medtronic, INC. | $105.90 | 2021-2023 | Interstim |
| Neotract INC. | $82.39 | 2019 | |
| Axonics, INC. | $71.43 | 2021-2023 | Axonics |
| Astellas Pharma Global Development | $68.50 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $45.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $45.06 | 2025 | Lynparza |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $41.77 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $33.98 | 2019 | |
| 180 Medical, INC. | $32.11 | 2019-2024 | Gentlecath |
| Endo Pharmaceuticals INC. | $31.75 | 2022-2023 | Xiaflex, Edex, Aveed |
| Dornier Medtech America, INC | $28.68 | 2020 | |
| Janssen Biotech, INC. | $26.84 | 2019-2024 | Balversa, Akeega, Erleada |
| Tolmar Pharmaceuticals, INC. | $20.42 | 2022 | |
| Merck Sharp & Dohme LLC | $18.97 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.16 | 2025 | Opdivo |
| Accord Healthcare, INC. | $17.67 | 2025 | |
| Calyxo, INC. | $17.35 | 2025 | Cvac Aspiration System |
| Novartis Pharmaceuticals Corporation | $17.11 | 2025 | |
| Tolmar, INC. | $17.10 | 2025 | Eligard, Jatenzo |
| Bayer Healthcare Pharmaceuticals INC. | $16.91 | 2019 | |
| Photocure INC | $15.93 | 2022 | |
| Allergan, INC. | $14.24 | 2022 | |
| Myovant Sciences INC. | $12.33 | 2021 | |
| Coloplast Corp | $12.03 | 2021 | |
| Karl Storz Endoscopy-America | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.